Advertisement
Canada markets open in 1 hour 48 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7265
    +0.0002 (+0.02%)
     

  • CRUDE OIL

    81.96
    -0.77 (-0.93%)
     

  • Bitcoin CAD

    89,883.16
    +3,479.05 (+4.03%)
     

  • CMC Crypto 200

    1,334.78
    +22.15 (+1.72%)
     

  • GOLD FUTURES

    2,390.20
    -7.80 (-0.33%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,488.75
    -58.50 (-0.33%)
     

  • VOLATILITY

    18.91
    +0.91 (+5.06%)
     

  • FTSE

    7,829.03
    -48.02 (-0.61%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6819
    -0.0002 (-0.03%)
     

Valeant won't pay whatever it takes for Allergan: CEO

Reuters

(Reuters) - Valeant Pharmaceuticals Inc won't pay whatever it takes to acquire rival Allergan Inc, and it will not turn its bid into an all-cash deal, Valeant Chief Executive Michael Pearson said on Tuesday in New York. Valeant and activist investor Bill Ackman made an unsolicited $47 billion bid to buy Botox maker Allergan as it seeks to become one of the world's five biggest drug companies. (Reporting by Bill Berkrot in New York; Writing by Rod Nickel in Winnipeg, Manitoba; Editing by Meredith Mazzilli)